Complete Story
12/19/2021
AMDA - The Society for PALTC Medicine | December 15
COMMERCIAL: COVID-19 Update
Headlines:
New/Updated Guidance
- WHO recommends against the use of convalescent plasma to treat COVID-19
- FDA: Omicron Variant: Molecular Tests That May Be Impacted
- HHS: Side-by-Side Overview of Outpatient Therapies Authorized for Treatment of Mild-Moderate COVID-19
Journal Articles/Preprints
- JAMDA: Growth of Physicians and Nurse Practitioners Practicing Full Time in Nursing Homes
- Significantly elevated antibody levels and neutralization titers in nursing home residents after SARS-CoV-2 BNT162b2 mRNA booster vaccination
- Significant reduction in vaccine-induced antibody levels and neutralization activity among healthcare workers and nursing home residents 6 months following COVID-19 BNT162b2 mRNA vaccination
- MMWR: SARS-CoV-2 B.1.1.529 (Omicron) Variant — United States, December 1–8, 2021
- MMWR: Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged 65 Years or Over — United States, August 13, 2021–November 19, 2021
- JAMDA: Trends in Post-Acute Care in US Nursing Homes: 2001-2017
- BNT162b2 Vaccine Booster and Mortality Due to Covid-19
- Comparison of rates of dementia among older adult recipients of two, one, or no vaccinations
Research Reports/White Papers
News/News Analysis
- CDC Nursing Home COVID-19 Vaccination Data Dashboard
- What omicron's fast spread could mean for the U.S. – and the world
- Reinfections Seen in Early U.S. Cases of Omicron
- What it’s like in geriatric medicine: Shadowing Dr. Steinberg
- Omicron variant more resistant to vaccine but causes less severe covid, major South African study concludes
- Providers receive $9 billion early holiday gift — Phase 4 Provider Relief Fund distributions
- Telehealth for kidney care receives mixed response from older adults, physicians
- Pfizer says its Covid pill will protect against severe disease, even from Omicron.